Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength

  • Lee, Jihye (Department of Preventive Medicine, Chung-Ang University College of Medicine) ;
  • Hong, Yeon-pyo (Department of Preventive Medicine, Chung-Ang University College of Medicine) ;
  • Shin, Hyun Ju (Namyangju City Hall) ;
  • Lee, Weonyoung (Department of Preventive Medicine, Chung-Ang University College of Medicine)
  • Received : 2015.09.22
  • Accepted : 2015.11.21
  • Published : 2016.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: We investigated the associations of sarcopenia-defined both in terms of muscle mass and muscle strength-and sarcopenic obesity with metabolic syndrome. Methods: Secondary data pertaining to 309 subjects (85 men and 224 women) were collected from participants in exercise programs at a health center in a suburban area. Muscle mass was measured using bioelectrical impedance analysis, and muscle strength was measured via handgrip strength. Sarcopenia based on muscle mass alone was defined as a weight-adjusted skeletal muscle mass index more than two standard deviations below the mean of a sex-specific young reference group (class II sarcopenia). Two cut-off values for low handgrip strength were used: the first criteria were <26 kg for men and <18 kg for women, and the second criteria were the lowest quintile of handgrip strength among the study subjects. Sarcopenic obesity was defined as the combination of class II sarcopenia and being in the two highest quintiles of total body fat percentage among the subjects. The associations of sarcopenia and sarcopenic obesity with metabolic syndrome were evaluated using logistic regression models. Results: The age-adjusted risk ratios (RRs) of metabolic syndrome being compared in people with or without sarcopenia defined in terms of muscle mass were 1.25 (95% confidence interval [CI], 1.06 to 1.47, p=0.008) in men and 1.12 (95% CI, 1.06 to 1.19, p<0.001) in women, which were found to be statistically significant relationships. The RRs of metabolic syndrome being compared in people with or without sarcopenic obesity were 1.31 in men (95% CI, 1.10 to 1.56, p=0.003) and 1.17 in women (95% CI, 1.10 to 1.25, p<0.001), which were likewise found to be statistically significant relationships. Conclusions: The associations of sarcopenia defined in terms of muscle mass and sarcopenic obesity with metabolic syndrome were statistically significant in both men and women. Therefore, sarcopenia and sarcopenic obesity must be considered as part of the community-based management of non-communicable diseases.

Keywords

References

  1. Shim MS, Lee MS, Oh NR, Kang KH. A study on duty awareness of public health-center workers. J Korea Conver Soc 2010;1(1): 83-91 (Korean).
  2. Byun DH, Kim EJ, Park MB, Son HR, Park HK, Kim CB. Accessible strategy of the registration & management of hypertension and diabetes mellitus patients through the public-private partnership: policy implications fron the Hongcheon-gun case. Korean J Health Educ Promot 2013;30(4):111-123 (Korean). https://doi.org/10.14367/kjhep.2013.30.4.111
  3. Ministry of Health and Welfare. Korea health statistics 2013: Korea National Health and Nutrition Examination Survey (KNHANES VI-1). Sejong: Ministry of Health and Welfare; 2014, p. 52 (Korean).
  4. Korea University Research and Business Foundation. Ansan community-based cohort study. Cheongju: Korea Centers for Disease Control and Prevention; 2013, p. 84 (Korean).
  5. Statistics Korea. Annual report on the causes of death statistics 2013. Daejeon: Statistics Korea; 2014, p. 12 (Korean).
  6. Hong S, Choi WH. Clinical and physiopathological mechanism of sarcopenia. Korean J Med 2012;83(4):444-454 (Korean). https://doi.org/10.3904/kjm.2012.83.4.444
  7. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997;127(5 Suppl):990S-991S. https://doi.org/10.1093/jn/127.5.990S
  8. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39(4):412-423. https://doi.org/10.1093/ageing/afq034
  9. Balagopal P, Rooyackers OE, Adey DB, Ades PA, Nair KS. Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am J Physiol 1997; 273(4 Pt 1):E790-E800. https://doi.org/10.1152/ajpcell.1997.273.3.C790
  10. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 2012;31(5):583-601. https://doi.org/10.1016/j.clnu.2012.06.010
  11. Hwang J, Lee W. Aging and sarcopenia: resistance exercise and protein intake in the elderly. Ewha J Human Move Sci 2009;12:15-20 (Korean).
  12. Zoico E, Di Francesco V, Guralnik JM, Mazzali G, Bortolani A, Guariento S, et al. Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes Relat Metab Disord 2004;28(2):234-241. https://doi.org/10.1038/sj.ijo.0802552
  13. World Health Organization. Ageing and life-course [cited 2009 Apr 30]. Available from: http://www.who.int/ageing/en/.
  14. Sayer AA, Dennison EM, Syddall HE, Gilbody HJ, Phillips DI, Cooper C. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care 2005;28(10): 2541-2542. https://doi.org/10.2337/diacare.28.10.2541
  15. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50(5):889-896. https://doi.org/10.1046/j.1532-5415.2002.50216.x
  16. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 2004;52(1):80-85. https://doi.org/10.1111/j.1532-5415.2004.52014.x
  17. Gale CR, Martyn CN, Cooper C, Sayer AA. Grip strength, body composition, and mortality. Int J Epidemiol 2007;36(1):228-235. https://doi.org/10.1093/ije/dyl224
  18. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 2008;11(6):693-700. https://doi.org/10.1097/MCO.0b013e328312c37d
  19. Klip A, Pâquet MR. Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 1990;13(3):228-243. https://doi.org/10.2337/diacare.13.3.228
  20. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37(12):1595-1607. https://doi.org/10.2337/diab.37.12.1595
  21. Walsh K. Adipokines, myokines and cardiovascular disease. Circ J 2009;73(1):13-18. https://doi.org/10.1253/circj.CJ-08-0961
  22. Solerte SB, Gazzaruso C, Bonacasa R, Rondanelli M, Zamboni M, Basso C, et al. Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. Am J Cardiol 2008; 101(11A):69E-77E.
  23. Sanada K, Miyachi M, Tanimoto M, Yamamoto K, Murakami H, Okumura S, et al. A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors. Eur J Appl Physiol 2010;110(1): 57-65. https://doi.org/10.1007/s00421-010-1473-z
  24. Chien MY, Huang TY, Wu YT. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc 2008;56(9):1710-1715. https://doi.org/10.1111/j.1532-5415.2008.01854.x
  25. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15(2): 95-101. https://doi.org/10.1016/j.jamda.2013.11.025
  26. Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One 2010;5(5):e10805. https://doi.org/10.1371/journal.pone.0010805
  27. Moon SS. Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Endocr J 2014;61(1):61-70. https://doi.org/10.1507/endocrj.EJ13-0244
  28. Kim TN, Yang SJ, Yoo HJ, Lim KI, Kang HJ, Song W, et al. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond) 2009; 33(8):885-892. https://doi.org/10.1038/ijo.2009.130
  29. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985) 2003;95(5):1851-1860. https://doi.org/10.1152/japplphysiol.00246.2003
  30. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) 2000;89(2):465-471. https://doi.org/10.1152/jappl.2000.89.2.465
  31. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004; 159(4):413-421. https://doi.org/10.1093/aje/kwh058
  32. Kim YS, Lee Y, Chung YS, Lee DJ, Joo NS, Hong D, et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci 2012; 67(10):1107-1113. https://doi.org/10.1093/gerona/gls071
  33. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112(17):2735-2752. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
  34. Park E, Choi SJ, Lee HY. The prevalence of metabolic syndrome and related risk factors based on the KNHANES V 2010. J Agric Med Community Health 2013;38(1):1-13 (Korean). https://doi.org/10.5393/JAMCH.2013.38.1.001
  35. Sayer AA, Syddall HE, Dennison EM, Martin HJ, Phillips DI, Cooper C, et al. Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study. QJM 2007;100(11): 707-713. https://doi.org/10.1093/qjmed/hcm095
  36. Gaster M, Vach W, Beck-Nielsen H, Schroder HD. GLUT4 expression at the plasma membrane is related to fibre volume in human skeletal muscle fibres. APMIS 2002;110(9):611-619. https://doi.org/10.1034/j.1600-0463.2002.1100903.x
  37. Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res 2004;12(6):887-888. https://doi.org/10.1038/oby.2004.107
  38. Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care 2003;6(3):295-299. https://doi.org/10.1097/01.mco.0000068965.34812.62
  39. Tanimoto Y, Watanabe M, Sun W, Sugiura Y, Tsuda Y, Kimura M, et al. Association between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in Japan. Arch Gerontol Geriatr 2012;55(2):e9-e13. https://doi.org/10.1016/j.archger.2012.06.015
  40. Tieland M, Dirks ML, van der Zwaluw N, Verdijk LB, van de Rest O, de Groot LC, et al. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012;13(8):713-719. https://doi.org/10.1016/j.jamda.2012.05.020

Cited by

  1. Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer vol.34, pp.30, 2016, https://doi.org/10.1200/jco.2016.67.4473
  2. Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study vol.11, pp.None, 2016, https://doi.org/10.2147/cia.s116430
  3. Age-Related Anabolic Resistance of Myofibrillar Protein Synthesis Is Exacerbated in Obese Inactive Individuals vol.102, pp.9, 2016, https://doi.org/10.1210/jc.2017-00869
  4. Impact of sarcopenia in the management of urological cancer patients vol.17, pp.5, 2017, https://doi.org/10.1080/14737140.2017.1301209
  5. Association between obesity with low muscle mass and dialysis mortality vol.47, pp.11, 2016, https://doi.org/10.1111/imj.13553
  6. International society of sports nutrition position stand: diets and body composition vol.14, pp.None, 2017, https://doi.org/10.1186/s12970-017-0174-y
  7. Current and future strategies for the nutritional management of cardiometabolic complications of androgen deprivation therapy for prostate cancer vol.30, pp.2, 2016, https://doi.org/10.1017/s0954422417000087
  8. Relative handgrip strength as a marker of metabolic syndrome: the Korea National Health and Nutrition Examination Survey (KNHANES) VI (2014–2015) vol.11, pp.None, 2018, https://doi.org/10.2147/dmso.s166875
  9. Muscle radiodensity and mortality in patients with colorectal cancer vol.124, pp.14, 2016, https://doi.org/10.1002/cncr.31405
  10. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project vol.108, pp.None, 2018, https://doi.org/10.1016/j.exger.2018.04.006
  11. Metabolic syndrome and disability in Chinese nonagenarians and centenarians vol.30, pp.8, 2016, https://doi.org/10.1007/s40520-017-0877-6
  12. Associations between Sarcopenia and Metabolic Risk Factors: A Systematic Review and Meta-Analysis vol.27, pp.3, 2018, https://doi.org/10.7570/jomes.2018.27.3.175
  13. Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer vol.19, pp.10, 2016, https://doi.org/10.3390/ijms19102999
  14. Sarcopenia and Its Implications for Metabolic Health vol.2019, pp.None, 2016, https://doi.org/10.1155/2019/8031705
  15. Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma vol.20, pp.3, 2016, https://doi.org/10.3390/ijms20030760
  16. Fat-to-muscle ratio is a useful index for cardiometabolic risks: A population-based observational study vol.14, pp.4, 2019, https://doi.org/10.1371/journal.pone.0214994
  17. CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation vol.51, pp.8, 2019, https://doi.org/10.1038/s41588-019-0470-3
  18. Comparison between grip strength and grip strength divided by body weight in their relationship with metabolic syndrome and quality of life in the elderly vol.14, pp.9, 2019, https://doi.org/10.1371/journal.pone.0222040
  19. Promoting mobility and healthy aging in men: a narrative review vol.30, pp.10, 2019, https://doi.org/10.1007/s00198-019-05080-w
  20. Association between underweight and pulmonary function in 282,135 healthy adults: A cross-sectional study in Korean population vol.9, pp.1, 2016, https://doi.org/10.1038/s41598-019-50488-3
  21. Association between the Thigh Muscle and Insulin Resistance According to Body Mass Index in Middle-Aged Korean Adults vol.44, pp.3, 2016, https://doi.org/10.4093/dmj.2019.0110
  22. Pre-Sleep Casein Protein Ingestion Does Not Impact Next-Day Appetite, Energy Intake and Metabolism in Older Individuals vol.12, pp.1, 2016, https://doi.org/10.3390/nu12010090
  23. Chrysanthemi Zawadskii var. Latilobum Attenuates Obesity-Induced Skeletal Muscle Atrophy via Regulation of PRMTs in Skeletal Muscle of Mice vol.21, pp.8, 2016, https://doi.org/10.3390/ijms21082811
  24. ASSOCIATION OF LOW MUSCLE MASS AND ISOKINETIC STRENGTH WITH METABOLIC SYNDROME vol.16, pp.2, 2016, https://doi.org/10.15586/jomh.v16i2.224
  25. The effect of short‐term exercise prehabilitation on skeletal muscle protein synthesis and atrophy during bed rest in older men vol.12, pp.1, 2021, https://doi.org/10.1002/jcsm.12661
  26. Myopenic obesity determined by visceral fat area strongly predicts long-term mortality in cirrhosis vol.40, pp.4, 2021, https://doi.org/10.1016/j.clnu.2020.09.016
  27. Cardiometabolic Profile of Different Body Composition Phenotypes in Children vol.106, pp.5, 2016, https://doi.org/10.1210/clinem/dgab003
  28. Skeletal mass indices are inversely associated with metabolically unhealthy phenotype in overweight/obese and normal-weight men: a population-based cross-sectional study vol.126, pp.4, 2016, https://doi.org/10.1017/s0007114520004262
  29. Relationship between socio-demographics, body composition, emotional state, and social support on metabolic syndrome risk among adults in rural Mongolia vol.16, pp.9, 2016, https://doi.org/10.1371/journal.pone.0254141
  30. Effects of different definitions of low muscle mass on its association with metabolic syndrome in older adults: A Korean nationwide study vol.21, pp.11, 2016, https://doi.org/10.1111/ggi.14277
  31. Sarcopenia, Obesity, and Sarcopenic Obesity: Relationship with Skeletal Muscle Phenotypes and Single Nucleotide Polymorphisms vol.10, pp.21, 2021, https://doi.org/10.3390/jcm10214933